A negative feedback loop mediated by STAT3 limits human Th17 responses

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1142-1150

  Purvis, Harriet A ^a,b   Anderson, Amy E ^a   Young, David A ^a   Isaacs, John D ^a   Hilkens, Catharien M U ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; CD45RO ANTIGEN; ECTONUCLEOTIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 23; NUCLEOTIDASE; PURINERGIC P2X7 RECEPTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH17 CELL; TISSUE INJURY;

CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; DOWN-REGULATION; FEEDBACK, PHYSIOLOGICAL; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKIN-17; PRIMARY CELL CULTURE; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; UP-REGULATION;

EID: 84906075907     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302467     Document Type: Article

References (52)

1. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
2. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H.Wang, Y.Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
3. Kuchroo, V. K., and A. Awasthi. 2012. Emerging new roles of Th17 cells. Eur. J. Immunol. 42: 2211-2214.
4. Sallusto, F., C. E. Zielinski, and A. Lanzavecchia. 2012. Human Th17 subsets. Eur. J. Immunol. 42: 2215-2220.
5. Weaver, C. T., C. O. Elson, L. A. Fouser, and J. K. Kolls. 2013. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8: 477-512.
6. Conti, H. R., F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206: 299-311.
7. Yi, T., Y. Chen, L. Wang, G. Du, D. Huang, D. Zhao, H. Johnston, J. Young, I. Todorov, D. T. Umetsu, et al. 2009. Reciprocal differentiation and tissuespecific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 114: 3101-3112.
8. Hill, G. R., S. D. Olver, R. D. Kuns, A. Varelias, N. C. Raffelt, A. L. Don, K. A. Markey, Y. A. Wilson, M. J. Smyth, Y. Iwakura, et al. 2010. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood 116: 819-828.
9. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204: 2803-2812.
10. Lowes, M. A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L. C. Zaba, A. S. Haider, E. P. Bowman, and J. G. Krueger. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128: 1207-1211.
11. Patel, D. D., D. M. Lee, F. Kolbinger, and C. Antoni. 2013. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann. Rheum. Dis. 72 (Suppl. 2): ii116-ii123.
12. Lemos, H. P., R. Grespan, S. M. Vieira, T. M. Cunha, W. A. Verri, Jr., K. S. Fernandes, F. O. Souto, I. B. McInnes, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha. 2009. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc. Natl. Acad. Sci. USA 106: 5954-5959.
13. van Hamburg, J. P., P. S. Asmawidjaja, N. Davelaar, A. M. Mus, E. M. Colin, J. M. Hazes, R. J. Dolhain, and E. Lubberts. 2011. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 63: 73-83.
14. Wu, C., N. Yosef, T. Thalhamer, C. Zhu, S. Xiao, Y. Kishi, A. Regev, and V. K. Kuchroo. 2013. Induction of pathogenic TH17 cells by inducible saltsensing kinase SGK1. Nature 496: 513-517.
15. Kleinewietfeld, M., A. Manzel, J. Titze, H. Kvakan, N. Yosef, R. A. Linker, D. N. Muller, and D. A. Hafler. 2013. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518-522.
16. Obermajer, N., J. L. Wong, R. P. Edwards, K. Chen, M. Scott, S. Khader, J. K. Kolls, K. Odunsi, T. R. Billiar, and P. Kalinski. 2013. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J. Exp. Med. 210: 1433-1445.
17. Yang, J., R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, M. Tang, et al. 2013. T cell-derived inducible nitric oxide synthase switches off TH17 cell differentiation. J. Exp. Med. 210: 1447.
18. Purvis, H. A., J. N. Stoop, J. Mann, S. Woods, A. E. Kozijn, S. Hambleton, J. H. Robinson, J. D. Isaacs, A. E. Anderson, and C. M. Hilkens. 2010. Lowstrength T-cell activation promotes Th17 responses. Blood 116: 4829-4837.
19. Liu, X. K., X. Lin, and S. L. Gaffen. 2004. Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J. Biol. Chem. 279: 52762-52771.
20. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
21. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363.
22. Milner, J. D., J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill, K. M. Elias, Y. Kanno, C. Spalding, H. Z. Elloumi, M. L. Paulson, et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
23. Ma, C. S., G. Y. Chew, N. Simpson, A. Priyadarshi, M. Wong, B. Grimbacher, D. A. Fulcher, S. G. Tangye, and M. C. Cook. 2008. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205: 1551-1557.
24. Durant, L., W. T. Watford, H. L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi, H. W. Sun, Y. Kanno, F. Powrie, and J. J. O'Shea. 2010. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32: 605-615.
25. Ju, J. H., Y. J. Heo, M. L. Cho, J. Y. Jhun, J. S. Park, S. Y. Lee, H. J. Oh, S. J. Moon, S. K. Kwok, K. S. Park, et al. 2012. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells. Arthritis Rheum. 64: 3543-3552.
26. Steinman, R. A., A. Wentzel, Y. Lu, C. Stehle, and J. R. Grandis. 2003. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene 22: 3608-3615.
27. Vultur, A., J. Cao, R. Arulanandam, J. Turkson, R. Jove, P. Greer, A. Craig, B. Elliott, and L. Raptis. 2004. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23: 2600-2616.
28. Corvaisier, M., Y. Delneste, H. Jeanvoine, L. Preisser, S. Blanchard, E. Garo, E. Hoppe, B. Barré, M. Audran, B. Bouvard, et al. 2012. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol. 10: e1001395.
29. Wakahara, K., N. Baba, V. Q. Van, P. Bégin, M. Rubio, P. Ferraro, B. Panzini, R. Wassef, R. Lahaie, Y. Caussignac, et al. 2012. Human basophils interact with memory T cells to augment Th17 responses. Blood 120: 4761-4771.
30. Ferran, M., A. B. Galván, C. Rincón, E. R. Romeu, M. Sacrista, E. Barboza, A. Giménez-Arnau, A. Celada, R. M. Pujol, and L. F. Santamaria-Babí. 2013. Streptococcus induces circulating CLA(+) memory T-cell-dependent epidermal cell activation in psoriasis. J. Invest. Dermatol. 133: 999-1007.
31. Fletcher, J. M., R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, C. O'Farrelly, N. Tubridy, and K. H. Mills. 2009. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol. 183: 7602-7610.
32. Chalmin, F., G. Mignot, M. Bruchard, A. Chevriaux, F. Végran, A. Hichami, S. Ladoire, V. Derangère, J. Vincent, D. Masson, et al. 2012. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36: 362-373.
33. Harris, T. J., J. F. Grosso, H. R. Yen, H. Xin, M. Kortylewski, E. Albesiano, E. L. Hipkiss, D. Getnet, M. V. Goldberg, C. H. Maris, et al. 2007. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179: 4313-4317.
34. Palmer, D. C., and N. P. Restifo. 2009. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 30: 592-602.
35. Chen, Z., A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, and J. J. O'Shea. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103: 8137-8142.
36. Qin, H., L. Wang, T. Feng, C. O. Elson, S. A. Niyongere, S. J. Lee, S. L. Reynolds, C. T. Weaver, K. Roarty, R. Serra, et al. 2009. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 183: 97-105.
37. Taleb, S., M. Romain, B. Ramkhelawon, C. Uyttenhove, G. Pasterkamp, O. Herbin, B. Esposito, N. Perez, H. Yasukawa, J. Van Snick, et al. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206: 2067-2077.
38. Kleinsteuber, K., K. Heesch, S. Schattling, C. Sander-Juelch, U. Mock, K. Riecken, B. Fehse, B. Fleischer, and M. Jacobsen. 2012. SOCS3 promotes interleukin-17 expression of human T cells. Blood 120: 4374-4382.
39. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
40. Gao, H., and P. A. Ward. 2007. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin. Ther. Targets 11: 869-880.
41. Zhao, M., B. Jiang, and F. H. Gao. 2011. Small molecule inhibitors of STAT3 for cancer therapy. Curr. Med. Chem. 18: 4012-4018.
42. Nanzer, A. M., E. S. Chambers, K. Ryanna, D. F. Richards, C. Black, P. M. Timms, A. R. Martineau, C. J. Griffiths, C. J. Corrigan, and C. M. Hawrylowicz. 2013. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1a,25-dihydroxyvitamin D3 in a glucocorticoidindependent fashion. J. Allergy Clin. Immunol. 132: 297-304.-e3.
43. Lappas, C. M., J. M. Rieger, and J. Linden. 2005. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J. Immunol. 174: 1073-1080.
44. Junger, W. G. 2011. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11: 201-212.
45. Schnurr, M., T. Toy, A. Shin, M. Wagner, J. Cebon, and E. Maraskovsky. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105: 1582-1589.
46. Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans, K. Honda, and K. Takeda. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455: 808-812.
47. Paustian, C., P. Taylor, T. Johnson, M. Xu, N. Ramirez, K. S. Rosenthal, S. Shu, P. A. Cohen, B. J. Czerniecki, and G. K. Koski. 2013. Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17. PLoS ONE 8: e54804.
48. Killeen, M. E., L. Ferris, E. A. Kupetsky, L. Falo, Jr., and A. R. Mathers. 2013. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. J. Immunol. 190: 4324-4336.
49. Shen, H., J. C. Goodall, and J. S. Hill Gaston. 2009. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60: 1647-1656.
50. Nistala, K., H. Moncrieffe, K. R. Newton, H. Varsani, P. Hunter, and L. R. Wedderburn. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58: 875-887.
51. Yamada, H., Y. Nakashima, K. Okazaki, T. Mawatari, J. I. Fukushi, N. Kaibara, A. Hori, Y. Iwamoto, and Y. Yoshikai. 2008. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 67: 1299-1304.
52. Moncrieffe, H., K. Nistala, Y. Kamhieh, J. Evans, A. Eddaoudi, S. Eaton, and L. R. Wedderburn. 2010. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 185: 134-143.